Mouse ADAM17 / TACE / CD156b Protein, His Tag
分子别名(Synonym)
ADAM17,TACE,CD156b
表达区间及表达系统(Source)
Mouse ADAM17, His Tag (AD7-M52H1) is expressed from human 293 cells (HEK293). It contains AA Pro 18 - Asp 563 (Accession # Q9Z0F8).
Predicted N-terminus: Pro 18, Asp 59 and Arg 215
蛋白结构(Molecular Characterization)

This protein carries a polyhistidine tag at the C-terminus.
The protein has a calculated MW of 63.4 kDa. The protein migrates as 19 kDa and 20 kDa (Propeptide), 55-66 kDa (Mature-ADAM17) and 75-94 kDa (Pro-ADAM17) under reducing (R) condition (SDS-PAGE) due to glycosylation.
内毒素(Endotoxin)
Less than 1.0 EU per μg by the LAL method.
纯度(Purity)
>90% as determined by SDS-PAGE.
制剂(Formulation)
Lyophilized from 0.22 μm filtered solution in 50 mM MES, 150 mM NaCl, pH6.5. Normally trehalose is added as protectant before lyophilization.
Contact us for customized product form or formulation.
重构方法(Reconstitution)
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
存储(Storage)
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.

背景(Background)
含去整合素和金属蛋白酶结构域的蛋白17(ADAM17)是去整合素和金蛋白酶ADAM蛋白家族的成员,也称为TNF-α转化酶、TNF-α转换酶和CD156b,CD156b含有一个去整合素结构域和一个肽酶M12B结构域。ADAM17可以将TNFα的膜结合前体切割成其成熟的可溶性形式。ADAM17还负责可溶性JAM3从内皮细胞表面的蛋白水解释放(通过相似性)和其他几种细胞表面蛋白的蛋白水解分泌,包括p75 TNF受体、白细胞介素1受体II型、p55 TNF受体、转化生长因子α、L-选择素、生长激素受体、MUC1和淀粉样前体蛋白。此外,ADAM17通过介导Notch的切割,产生称为Notch细胞外截短的膜相关中间片段,从而充当Notch通路的激活剂。
关键字: ADAM17;ADAM17蛋白;ADAM17重组蛋白;ACRO;百普赛斯;
百普赛斯集团ACROBiosystems Group(股票代码:301080)是成立于2010年的跨国生物科技公司,是为全球生物医药、健康产业领域提供关键生物试剂产品及解决方案的行业平台型基石企业。2021年在创业板上市。百普赛斯集团业务遍布全球,横跨亚洲、北美洲、欧洲,在中国、美国、瑞士等12个城市设有办公室、研发中心及生产基地。目前累计服务客户超6000家,与全球Top 20医药企业均建立了长期、稳定的合作伙伴关系。集团旗下拥有品牌ACROBiosystems百普赛斯、bioSeedin柏思荟、Condense Capital垦拓资本和ACRODiagnostics百斯医学等。